Atai Life Sciences N.V.

NASDAQ: ATAI · Real-Time Price · USD
2.48
0.17 (7.36%)
At close: Jun 02, 2025, 11:28 AM

Atai Life Sciences Revenue Breakdown

Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Research And Development Services Revenue 300K 300K 200K 600K
Research And Development Services Revenue Growth 0.00% +50.00% -66.67% n/a

Operating Expense Breakdown

Period Ending Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021 Dec 31, 2020 Sep 30, 2020 Jun 30, 2020 Mar 31, 2020
Selling, General, and Administrative Revenue 10.6M 11.32M 10.27M 13.4M 12.46M 19.42M 13.63M 16.56M 13.97M 15.73M 19.42M 17.22M 17.98M 25.88M 20.26M 37.33M 9.27M 71.98M 4.33M 2.85M 1.57M
Selling, General, and Administrative Revenue Growth -6.37% +10.26% -23.38% +7.56% -35.87% +42.49% -17.68% +18.53% -11.17% -19.01% +12.76% -4.23% -30.51% +27.70% -45.72% +302.58% -87.12% +1563.24% +51.81% +81.59% n/a
Research and Development Revenue 11.33M 18.94M 12.38M 12.61M 11.45M 14.05M 13.29M 15.48M 19.28M 21.88M 19.03M 17.95M 15.46M 19.53M 13.36M 16.03M 5.58M 3.35M 3.06M 2.85M 2.14M
Research and Development Revenue Growth -40.20% +53.04% -1.81% +10.12% -18.56% +5.76% -14.13% -19.73% -11.86% +14.97% +6.01% +16.10% -20.83% +46.13% -16.62% +186.95% +66.62% +9.61% +7.15% +33.12% n/a